ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

The Latest on X

About ASN

ASN / About /

Roslyn B. Mannon, MD, FASN, BRCU Faculty

Dr. Roslyn Bernstein Mannon is a Professor of Medicine, Pathology and Microbiology at the University of Nebraska Medical Center, Vice-Chair for Research and Associate Chief of Nephrology for Research. Dr. Mannon is a Fellow of the American Society of Nephrology and American Society of Transplantation. She received her MD from Duke University, completing Internal Medicine internship, residency and Nephrology fellowship and Chief Resident at Duke. Her career includes serving as Medical Director for the Kidney/Pancreas NIDDK intramural transplant program and at the Birmingham VA Medical Center and Section Chief of Transplant Nephrology at the University of Alabama at Birmingham. Dr. Mannon is a past-president of the AST and is a Deputy Editor of the American Journal of Transplantation. She is the past-Chair of Women in Transplantation, an initiative of the Transplantation Society, Chair of the Policy and Advocacy Committee of the American Society of Nephrology, and co-Chair of the Scientific Registry of Transplant Recipients Review Committee. Dr. Mannon's laboratory research focuses on mechanisms of chronic graft injury using in vitro and rodent models and is funded by the Veterans Administration Merit Award. She has published about 200 peer-reviewed publications on the mechanisms of chronic allograft failure following transplantation, post-transplant complications, therapeutics, and immune monitoring.

Current Position/Titles:

Professor of Internal Medicine (with tenure)

Vice Chair of Research; Associate Chief for Research Division of Nephrology

Professor of Pathology, Microbiology, and Immunology (courtesy) University of Nebraska Medical Center, Omaha, NE

Degrees/Training:

BA., The Johns Hopkins University, 1981

M.D., Duke University School of Medicine, Durham, NC 1985

Internal Medicine Residency: Duke University Medical Center 1985-1988

Nephrology Fellowship: Duke University Medical Center 1988-1991

Chief Resident: Department of Medicine, DUMC 1990-1991

ASN Service:

Education: Education Committee 2008-2013 | Post Graduate Education Committee 2006-2009 | ASN Kidney Week Abstract Reviewer multiple years 1994‐2022 | Program Committee Section Chair: Transplantation 2001, 2002, 2008 | Program Committee Renal Week 2006 |Team Leader, Transplantation, Renal Weekends/Highlights 2011-2016 | Faculty, BRCU 2016

Research: Grants Committee, 2003-2005, 2018-2021, 2023 | Kidney Health Initiative CFAST Project Lead 2015-2017.

Editorial Boards: Clinical Journal of the American Society of Nephrology 10/2010-07/2013 | Associate Editor, Clinical Journal of the American Society of Nephrology, 07/2013-09/2015 | Associate Editor, Journal of the American Society of Nephrology, 10/2017-07/2019 Guest Editor, Clinical Journal of the American Society of Nephrology 2008; Vol. 3(Supplement 2): p S27-S125

Policy/Advocacy: Transplant Advisory Group 11/2009-11/2012 | COVID-19 Task Force; Transplantation, 2020-2021 | Public Policy Committee, 2018 - present | Chair 2021-present | Transplantation Work Group 2022‐present.

Other: Nominating Committee 2007‐2008.

Leadership positions:

President, American Society of Transplantation (AST) 2012-2013; Chair American Transplant Congress 2012; Councilor AST 2007-2013; Chair Education Committee AST 2005-2007; Co-Chair Public Policy Committee AST 2013-2017; Grants Committee AST 2007-2012 | Chair, Scientific Registry of Transplant Recipients 2020-2022 | Chair, Women in Transplantation, Transplantation Society 2020-2022 | Trustee Banff Foundation for Allograft Pathology 2022-present | Scientific Review Board Cystinosis Research Network 2011-present | Grants Committee National Kidney Foundation 2002-2010; Chair 2008-2009 | Ad Hoc member NIH/CSR Study Sections KUF, NIAID SEP Nonhuman Primate Transplant Tolerance, VA ORD Nephrology | Chair, Ancillary Studies Committee, NIDDK APOL1 Long-Term Kidney Outcomes Study (APOLLO) | Deputy Editor, American Journal of Transplantation 2019-present.

Honors:

Alpha Epsilon Delta Honor Society 1979, Phi Beta Kappa 1980, Alpha Omega Alpha 1985, Young Investigator Award American Society of Transplant Physicians 1990, NIAID Mentored Clinical Scientist Development Award 1996; Volunteer Service Award National Kidney Foundation of the Nation?s Capital 2002; 2008, Best Doctors US 2009-2020, Castle Connolly Top Doctor 2012-2020, 5-Star Award Department of Veterans Affairs 2018, Distinguished Scientist UNMC 2022, Senior Achievement Award American Society of Transplantation 2022, Transplant Therapeutic Consortium Trailblazer Award 2022, Barbara T Murphy Endowed Lectureship American Society of Nephrology Kidney Week 2022; American Association of Kidney Patients Medal of Excellence 2024.

Board Certification:

Internal Medicine, Nephrology (enrolled in MOC)

Research Interests:

My research focuses on late kidney allograft injury with the goal of improving long-term survival. In addition to active bench lab efforts, I'm a primary investigator of novel therapeutics, both NIH and industry funded, and have participated in multicenter observational cohort studies investigating graft demise, incorporating clinical, immunological, and genetic factors. Further, I participate in the Banff Allograft Pathology Foundation and the Sensitization in Transplantation: Assessment of Risk (STAR) initiatives, developing standardized definitions of immune injury and risk. I maintain active research funding through the Veterans Administration and a co-PI for the NIDDK funded APOL1 Kidney Transplant Outcomes Network (APOLLO).

Personal Statement:

As a clinician-scientist, I have worked in several academic and government settings, and deeply familiar with the challenges of our field. These include workforce, improving patient access and outcomes, and innovation of novel therapies and devices to improve kidney care. My prior service in ASN has provided me a practical understanding of the organization's goals and functions, particularly the commitment ASN has in advocacy. Moreover, my leadership in other organizations and collaboration with other agencies has provided me the ability to network and collaborate effectively. I look forward to leveraging my enthusiasm and energy for our members and the Society.